Overview: Stanley Cohen was an American biochemist whose laboratory discoveries reshaped understanding of how cells grow, differentiate and respond to signals. He shared the 1986 Nobel Prize in Physiology or Medicine for work that identified protein growth factors and clarified the molecular events that control cell proliferation. His research bridged basic biology and medical application and helped open new routes for cancer therapy and biotechnology. For a concise profile, see biochemist profile.

Major scientific contributions

Cohen is best known for isolating and characterizing epidermal growth factor (EGF) and for demonstrating the existence of specific cellular receptors that bind growth factors. These findings provided a molecular explanation for how external signals direct cell growth and division. The discovery illuminated mechanisms underlying normal development and disease, particularly cancer, where signaling pathways can become dysregulated. Summaries of his scientific work are available at research summaries.

Genetic engineering and early recombinant DNA work

In the early 1970s Cohen collaborated indirectly with contemporaries who developed plasmid-based cloning techniques. His laboratory experiments, together with related work by others, were among the first to demonstrate that DNA molecules can be isolated, manipulated and transferred across organisms. This body of work, which is part of the history of genetic engineering, helped establish methods that later enabled gene cloning, molecular diagnostics and the biotech industry. The partnership and scientific link with colleague Herbert Boyer is often cited in accounts of those formative years.

Impact on medicine and biotechnology

The conceptual advance of growth factors and receptors informed drug discovery: pharmaceutical approaches that target growth factor receptors (for example, EGFR inhibitors) trace their rationale to Cohen's findings. His work contributed to a shift from descriptive pathology toward molecularly targeted therapies and influenced how researchers design anti-cancer agents and regenerative medicine strategies. Broader discussions of cancer biology reference these developments at cancer research.

Notable facts and legacy

  • Recipient of the 1986 Nobel Prize in Physiology or Medicine for discoveries concerning growth factors.
  • Recognized as a key figure in the early era of recombinant DNA and biotechnology development.
  • His discoveries connected basic biochemical research to practical clinical applications, changing approaches to drug design and molecular medicine.

Cohen's career exemplifies how molecular discoveries can lead to both conceptual advances and tangible medical tools. For further context on his life and influence, consult general biographical sources and scientific retrospectives linked at biochemist profile and research summaries.